Improving the capture and reporting of adverse events in clinical trials of non-pharmacological interventions: learnings from the PaCCSC/CST membership
We provide recommendations for an AE-reporting framework for future trials that encompass risks unique to non-pharmacological interventions and all individuals involved. By focusing on these directions, we can streamline the process of capturing and reporting AEs and contribute to more impactful and sustainable outcomes.
Authors
- Vanessa Yenson (ORCID: https://orcid.org/0000-0002-7112-0785)
- Imelda Gilmore (ORCID: https://orcid.org/0000-0001-8177-5833)
- Layla Edwards (ORCID: https://orcid.org/0000-0001-9951-237X)
- Sally Fielding
- Celia Marston (ORCID: https://orcid.org/0000-0002-6400-804X)
- Andrea Cross (ORCID: https://orcid.org/0000-0003-1477-4536)
- Belinda Fazekas
- Domenica Disalvo (ORCID: https://orcid.org/0000-0001-9179-7702)
- Meera Agar (ORCID: https://orcid.org/0000-0002-6756-6119)
- Annmarie Hosie (ORCID: https://orcid.org/0000-0003-1674-2124)
- R. Moussa (ORCID: https://orcid.org/0000-0003-0393-2666)
- Linda Brown (ORCID: https://orcid.org/0000-0003-4892-5822)
- John Stubbs
- Jack Power
Institutions
- University of Technology Sydney (AU)
- The Royal Melbourne Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- St Vincent's Health (AU)
- Cancer Trials Australia (AU)
- Monash Health (AU)
- St Vincent's Clinic (AU)
- Monash University (AU)
- The University of Notre Dame Australia (AU)
Publication Details
- Journal
- Trials
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1186/s13063-025-08801-1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00